- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
6
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
6 companies
Sinopharm Group
Market Cap: HK$50.4b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$16.16
7D
-0.9%
1Y
-12.1%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.7b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$8.63
7D
0.3%
1Y
-29.6%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$3.5b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$10.06
7D
16.0%
1Y
-50.1%
Chaoju Eye Care Holdings
Market Cap: HK$1.6b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.35
7D
-5.2%
1Y
-17.5%
Sisram Medical
Market Cap: HK$1.1b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.31
7D
2.7%
1Y
-46.9%
Yonghe Medical Group
Market Cap: HK$1.1b
Provides hair-related healthcare services in China.
2279
HK$2.10
7D
3.4%
1Y
27.3%